Arca
Skip to content
Tools
Tools

Peritonitis

Drug research and approvals for peritonitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 12 studies of peritonitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 12
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 12 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

6 approved, 10 in phase 3, 1 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Ceftazidime, Amikacin, Clindamycin phosphate, Anidulafungin, Tazobactam, Piperacillin

Norfloxacin
Phase 3 Topoisomerase IV inhibitor
Rifaximin
Phase 3 Bacterial DNA-directed RNA polymerase inhibitor
Ciprofloxacin
Phase 3 Bacterial DNA gyrase inhibitor
Cefotaxime
Phase 3 Bacterial penicillin-binding protein inhibitor
Gemifloxacin
Phase 3 DNA gyrase inhibitor
Ceftriaxone
Phase 3 Bacterial penicillin-binding protein inhibitor
Doripenem
Phase 3 Bacterial penicillin-binding protein inhibitor
Nitazoxanide
Phase 3 Pyruvate:ferredoxin oxidoreductase inhibitor
Co-trimoxazole
Phase 3 Bacterial dihydrofolate reductase inhibitor
Itopride
Phase 3 Dopamine D2 receptor antagonist
Vancomycin
Phase 1 Peptidoglycan inhibitor

How Its Trials Ended

187 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 39 whose ending is known, 28% met their primary endpoint, 5% missed it and 67% stopped early.

  • Completed, result not reported7741%
  • Status unknown4021%
  • Ongoing3117%
  • Stopped: other or unclear147%
  • Met its primary endpoint116%
  • Stopped: enrollment or feasibility74%
  • Missed its primary endpoint21%
  • Stopped: lack of efficacy21%
  • Stopped: safety11%
  • Stopped: sponsor or business decision11%
  • Stopped: funding11%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.